BMJ  2003;327:1181-1182 (22 November), doi:10.1136/bmj.327.7425.1181

Editorial

Diastolic heart failure

The condition exists and needs to be recognised, prevented, and treated

Diastolic heart failure refers to the clinical syndrome of heart failure with a preserved left ventricular ejection fraction (0.50 or more) in the absence of major valve disease.¹ About a third of patients with heart failure seen by clinicians have diastolic heart failure as defined above.² A simple classification of heart failure into systolic versus diastolic is useful because the two conditions have a distinctive pathophysiology and different prognoses.

Although diastolic heart failure is common in clinical practice worldwide,^{3 4 5} its existence has been questioned for several reasons. Firstly, investigators have questioned whether these patients truly have heart failure or if they actually have conditions such as obesity or pulmonary disease that can mimic heart failure.⁶ Doubts regarding diastolic heart failure are cast especially because the diagnosis of heart failure is partly a clinical one and prone to error. When the left ventricular ejection fraction is low the diagnosis of heart failure is seldom questioned—clinicians seem more willing to accept a diagnosis of systolic heart failure.^w1 Fortunately the advent of biomarkers such plasma B-type natriuretic peptides should help confirm the presence of heart failure in patients with suspected diastolic heart failure.^w2

A second area of controversy is that while investigators may agree that some patients with heart failure do have a normal ejection fraction, they doubt if the underlying mechanism is truly left ventricular diastolic dysfunction, as implied by the term diastolic heart failure. Some of these patients have subtle abnormalities of systolic function (although the ventricular ejection fraction is normal).^w3 In some case series the relations between left ventricular pressure and volume on cardiac catheterisation do not conform to a classical pattern of diastolic dysfunction.⁷ Partly due to these debates the evidence base for the diagnosis and treatment of diastolic heart failure has lagged behind systolic heart failure (table). Recent guidelines for clinical practice from the National Institute for Clinical Excellence in the United Kingdom focus almost exclusively on the management of systolic heart failure, with a token reference to patients with suspected diastolic heart failure being "referred for specialist assessment."⁸

View this table: [in this window] [in a new window]   Comparison of evidence base for evaluation and treatment of systolic versus diastolic heart failure

 

Clinically patients with diastolic heart failure are elderly, more likely to be women, and often have a raised blood pressure, and associated ventricular hypertrophy.² However, clinical characteristics by themselves cannot distinguish reliably systolic from diastolic heart failure.² It is therefore important to obtain an imaging study, typically echocardiography, to estimate left ventricular ejection fraction to make this distinction. Specific assessment of left ventricular diastolic function may not be necessary as such abnormalities are universal in patients with diastolic heart failure.⁹ Studies have also established that ejection fraction remains fairly invariant in diastolic heart failure, so that treatment of heart failure should be initiated and an imaging study can be obtained once the patient is clinically stable.¹⁰

What is known about diastolic heart failure Diastolic heart failure is common in clinical practice A diagnosis of diastolic heart failure may be considered in patients with heart failure who have a normal left ventricular ejection fraction (0.50 or more) Diastolic heart failure is associated with a mortality risk four times that of controls without heart failure Current treatment of diastolic heart failure is empirical Prevention of diastolic heart failure can be achieved through better control of hypertension and other cardiovascular risk factors in the community

The pathophysiology of diastolic heart failure is characterised by a low cardiac output that results typically from a ventricle that has thick walls but a small cavity (increased left ventricular mass/volume ratio).¹¹ The left ventricle is stiff. It relaxes slowly in early diastole and offers greater resistance to filling in late diastole, so that diastolic pressures are elevated. The low cardiac output manifests as fatigue, while the higher end diastolic pressure is transmitted backwards through the valveless pulmonary veins to the pulmonary capillaries, resulting in exertional dyspnoea. These pathophysiological abnormalities trigger neurohormonal activation as happens in systolic heart failure. Symptoms may be unmasked by exercise because, unlike normal people, patients with diastolic heart failure are unable to augment their stroke volume by increasing their left ventricular end diastolic volume (Frank-Starling mechanism). These patients often have an exaggerated response of systolic blood pressure to exercise. Mechanisms contributing to abnormal left ventricular diastolic properties include stiff large arteries, hypertension, ischaemia, diabetes, and intrinsic myocardial changes with or without associated hypertrophy.¹¹

The objectives of treatment are similar to those for systolic heart failure—relief of acute symptoms, enhancement of chronic exercise tolerance and quality of life, reduction of hospital readmissions, and improvement of survival. Acute treatment includes relief of precipitating factors, cautious use of diuretics, blood pressure control, relief of ischaemia, and control of ventricular rate in patients with atrial fibrillation. Chronic treatment includes restriction of dietary sodium and control of hypertension. The role of agents that improve left ventricular relaxation is not established. Randomised controlled clinical trials are in progress and will enable replacement of empirical treatment strategies with evidence based ones. A single large randomised clinical trial of patients with heart failure and a preserved left ventricular ejection fraction (> 0.40) was recently published (CHARM-Preserved trial).¹² In that trial, treatment with candesartan (an angiotensin receptor blocker) had a modest impact on reducing future hospital readmissions for heart failure compared with placebo.

Mortality of diastolic heart failure patients is four times that of age and sex matched controls without heart failure.⁵ The prognosis of diastolic heart failure is generally better than that of systolic heart failure when ambulatory patients are compared, but similar when hospitalised or very elderly patients with heart failure are investigated.

Asymptomatic left ventricular systolic dysfunction can be identified readily with echocardiographic assessment of left ventricular ejection fraction and then treated with angiotensin converting enzyme inhibitors to prevent progression to heart failure.^w4 In comparison the identification of "subclinical diastolic dysfunction" poses a challenge because of the lack of a single, non-invasive gold standard test. We need to develop biomarkers or imaging tests that can reliably identify major diastolic dysfunction, are inexpensive, reproducible, and easy to use and interpret by clinicians. While Doppler echocardiography has aided the diagnosis of diastolic dysfunction, altered transmitral filling patterns are ubiquitous in elderly patients. Important advances in assessment of left ventricular diastolic function (such as colour-M-mode and tissue Doppler imaging) will probably enhance our ability to identify individuals at high risk of developing diastolic heart failure. Currently we do not know at what point along the spectrum of diastolic filling abnormalities an intervention should be considered necessary to prevent progression to heart failure.

Studies are under way also to understand the environmental and genetic underpinnings of raised blood pressure, vascular stiffness, and left ventricular hypertrophy, known precursors of diastolic heart failure. The optimal management of diastolic heart failure and of asymptomatic diastolic dysfunction is work in progress. The best strategy at present to prevent diastolic heart failure is to achieve better control of high blood pressure and other cardiovascular risk factors in the community.

Boston University School of Medicine, 715 Albany St, Boston, MA 02118 USA (vasan{at}fram.nhlbi.nih.gov)

---

Additional references w1-w4 appear on bmj.com

Competing interests: None declared.

References

1. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101: 2118-21.[Free Full Text]
2. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26: 1565-74.[Abstract]
3. Ibrahim BS. The frequency of systolic versus diastolic heart failure in an Egyptian cohort. Eur J Heart Fail 2003;5: 41-5.[CrossRef][ISI][Medline]
4. Sanderson JE, Chan SK, Chan WW, Hung YT, Woo KS. The aetiology of heart failure in the Chinese population of Hong Kong—a prospective study of 730 consecutive patients. Int J Cardiol 1995;51: 29-35.[CrossRef][ISI][Medline]
5. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33: 1948-55.[Abstract/Free Full Text]
6. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ 2000;321: 215-8.[Abstract/Free Full Text]
7. Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003;107: 656-8.[Free Full Text]
8. Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. Clinical guideline 5. London: National Institute for Clinical Excellence, 2003.
9. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001;104: 779-82.[Abstract/Free Full Text]
10. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344: 17-22.[Abstract/Free Full Text]
11. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288: 2144-50.[Abstract/Free Full Text]
12. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362: 777-81.[CrossRef][ISI][Medline]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ahmed, A. (2006). 1 year mortality after first hospital admission for heart failure was similar in patients with preserved or reduced ejection fraction. Evid. Based Med. 11: 185-185 [Full text]  
• Gillespie, N. D (2006). The diagnosis and management of chronic heart failure in the older patient. Br Med Bull 75-76: 49-62 [Abstract] [Full text]  
• (2004). Hit Parade. BMJ 328: 173-173 [Full text]  

Rapid Responses:

Read all Rapid Responses

diastolic failure a definite entity

manan vasenwala md, mrcp (uk)
bmj.com, 21 Nov 2003 [Full text]

Diastolic heart failure- how little we still know

Paresh A Mehta
bmj.com, 24 Nov 2003 [Full text]

Every one should know

Radhakrishnan Ramaraj, et al.
bmj.com, 24 Nov 2003 [Full text]

Diastolic heart failure

Habib-ur- Rehman
bmj.com, 28 Nov 2003 [Full text]

Diastolic heart failure in the elderly: a need for a new hemodynamic approach.

Stephane Arques
bmj.com, 29 Nov 2003 [Full text]

Diastolic heart failure- a practical perspective?

Aresh Anwar, et al.
bmj.com, 29 Nov 2003 [Full text]